IRIS
FERRERI, ANDRES JOSE MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.317
NA - Nord America 905
AS - Asia 571
SA - Sud America 18
OC - Oceania 10
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 893
SE - Svezia 606
SG - Singapore 329
RU - Federazione Russa 287
IT - Italia 177
CN - Cina 83
FI - Finlandia 67
GB - Regno Unito 56
IE - Irlanda 33
DE - Germania 32
JP - Giappone 28
IN - India 25
HK - Hong Kong 22
IR - Iran 16
KR - Corea 13
PT - Portogallo 13
ES - Italia 10
SA - Arabia Saudita 10
TR - Turchia 10
AU - Australia 9
NL - Olanda 9
CL - Cile 8
FR - Francia 7
MX - Messico 7
EC - Ecuador 6
ID - Indonesia 6
GG - Guernsey 5
NO - Norvegia 5
CA - Canada 4
EG - Egitto 4
CH - Svizzera 3
IQ - Iraq 3
LB - Libano 3
PL - Polonia 3
TW - Taiwan 3
CZ - Repubblica Ceca 2
MA - Marocco 2
MM - Myanmar 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
YE - Yemen 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
EE - Estonia 1
EU - Europa 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
VN - Vietnam 1
Totale 2.831
Salva come PNG Salva come JPEG
Città #
Lawrence 266
Princeton 266
Singapore 181
Moscow 118
Helsinki 65
New York 63
Shanghai 63
Milan 53
Ashburn 45
Dublin 33
Boardman 25
Los Angeles 24
Hong Kong 21
Leicester 18
Tokyo 15
Daejeon 11
Rome 10
Fremont 9
Naples 9
Washington 9
Dallas 8
Kish 8
Santiago 8
Chicago 7
Mumbai 7
Pune 7
Rotherham 7
Azogues 6
Ferrara 6
Jakarta 6
Pisa 6
Borås 5
Boydton 5
Buccinasco 5
Guernsey 5
Falkirk 4
Hoofddorp 4
Izmir 4
Makkah 4
Perugia 4
Seattle 4
Adana 3
Andover 3
Augsburg 3
Barnet 3
Bologna 3
Brixen 3
Ciudad Nezahualcoyotl 3
Durham 3
Erbil 3
Hamm 3
Hanover 3
Krakow 3
League City 3
North Augusta 3
Pearland 3
Santa Clara 3
Seville 3
St Petersburg 3
Wednesbury 3
Ahmedabad 2
Albizzate 2
Alexandria 2
Arequipa 2
Aveiro 2
Barcelona 2
Blackheath 2
Boston 2
Brisbane 2
Buk-gu 2
Buscate 2
Castelo do Neiva 2
Chennai 2
Dammam 2
Deiva Marina 2
Delhi 2
Egham 2
Foggia 2
Fort Gibson 2
Freiburg im Breisgau 2
Gaziantep 2
Guadalajara 2
Hackney 2
Hakusancho-sada 2
Jeddah 2
Jinan 2
Kansas City 2
Kasumicho 2
Kuala Lumpur 2
Kyauk Se 2
La Seyne-sur-Mer 2
Larkana 2
London 2
Melbourne 2
Mestre 2
Mexico City 2
Milwaukee 2
Montecorvino Pugliano 2
Muscat 2
Neem ka Thana 2
Totale 1.561
Salva come PNG Salva come JPEG
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 219
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 49
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 37
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 32
Cyclin D3 immunoreactivity (IR) is an independent predictor of survival and drives the correct assessment of p27(KIP1) IR prognostic role in primary gastric lymphomas (PGL). 31
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 26
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 26
Cyclin D3 (CyD3) immunoreactivity (IR) is an independent predictor of survival and drives the correct assessment of p27 IR prognostic role in primary gastric lymphomas (PGL) 24
Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thickness 23
Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis 22
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 22
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG) 22
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 21
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 20
A multicenter study of treatment of primary CNS lymphoma 18
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 18
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 18
Chronic lymphocytic leukemia 17
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 17
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 17
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 17
Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients 17
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 17
Breaching the blood–brain tumor barrier for tumor therapy 17
High-dose sequential chemoimmunotherapy supported by autologous stem cell transplantation in patients with systemic B-cell lymphoma and central nervous system involvement: interim analysis of a multicentre phase II Trial 16
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 15
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 15
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 15
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 15
Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods 15
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients 14
Primary cardiac lymphoma in immunocompetent patients - Diagnostic and therapeutic management 14
Ocular Adnexal Lymphoma: Diffusion-weighted MR Imaging for Differential Diagnosis and Therapeutic Monitoring 14
F-18-FDG pet after allogeneic stem cell transplantation in lymphoid malignancies: A useful tool to guide and monitor post-transplant immunotherapy 14
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome 14
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 14
Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis 14
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 14
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms 13
Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma 13
Bugs and marginal zone lymphoma of the ocular adnexae: is the future already here? 13
Allografting for patients with advanced hematological malignancies: Non-myeloablative conditioning followed by the reinfusion of lymphocytes engineered with HSV thymidine kinase gene. 13
MATILDE chemotherapy regimen for primary CNS lymphoma Results at a median follow-up of 12 years 13
Genomic profiles of MALT lymphomas: variability across anatomical sites 13
Chronic lymphocytic leukaemia 13
ABVD CAN BE SAFELY ADMINISTERED REGARDLESS OF ABSOLUTE NEUTROPHIL COUNT AND WITHOUT G-CSF SUPPORT IN HODGKIN'S LYMPHOMA PATIENTS 13
Primary central nervous system lymphoma 13
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation 12
Microvessel density is an independent predictor of survival in multiple myeloma patients. 12
Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-Cell gastric lymphomas 12
Questions and answers in the management of primary central nervous system and ocular lymphomas 12
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 11
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 11
Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma 11
Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options 11
Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis 11
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome 11
Immunoglobulin Gene Repertoire in Ocular Adnexa Lymphomas (OAL): Hints on the Nature of the Antigenic Stimulation 11
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21 11
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 11
Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas 11
Rituximab improves outcome in Western patients with intravascular large B-cell lymphoma (IVL) 11
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 11
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma 11
Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy 11
Le infezioni erpetiche nel paziente immunocompromesso 11
Targeted therapies make room, anti-CD79b agents are coming 10
Prevention and management of secondary central nervous system lymphoma 10
Gastric lymphoma: The histology report 10
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 10
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 10
The impact of histopathologic diagnosis on the proper management of testis neoplasms 10
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 10
Irradiation fields and doses in glioblastoma multiforme: Are current standards adequate? 10
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma 10
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions 10
Randomized phase II trial on primary chemotherapy (CHT) with high-dose methotrexate (MTX) alone or associated with high-dose cytarabine (ARAC) for patients (PTS) with primary CNS lymphoma (PCNSL) 10
Extranodal non-gastric malt lymphomas: An international survey of 278 cases. 10
Therapeutic role of rituximab in the treatment of intravascular lymphoma 10
Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae 10
Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation 10
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy 10
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies 10
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma 10
Reply to A. Korfel et al 10
Up-front chemotherapy (CHT) containing high-dose methotrexate (HDMTX) followed or not by radiotherapy (RT) in Primary CNS lymphoma (PCNSL): a critical review of prospective trials 10
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES 10
Primary central nervous system lymphoma in immunocompetent patients 10
Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion 10
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma 10
Erratum to ‘How we treat primary central nervous system lymphoma’: [ESMO Open Volume 6, Issue 4, August 2021, 100213] (ESMO Open (2021) 6(4), (S2059702921001745), (10.1016/j.esmoop.2021.100213)) 9
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial 9
New hopes in relapsed refractory primary central nervous system lymphoma 9
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy 9
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: A FIL study 9
Chlamydial infection: the link with ocular adnexal lymphomas 9
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study 9
Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients. 9
Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes? 9
Low sensitivity of computed tomography in the staging of gastric lymphomas of mucosa-associated lymphoid tissue - Impact on prospective trials and of ordinary clinical practice 9
Totale 1.610
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.829
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 1 0 0 1 0 1 0 0 0
2020/202134 0 0 0 2 2 3 23 0 3 1 0 0
2021/2022230 0 0 2 71 9 6 15 90 4 5 1 27
2022/20231.328 620 271 55 6 9 135 42 85 53 10 17 25
2023/2024896 39 36 42 58 237 121 57 67 36 52 47 104
2024/2025614 554 60 0 0 0 0 0 0 0 0 0 0
Totale 3.124